News
Corning (GLW) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Corning (GLW) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Analysts Estimate Edison International (EIX) to Report a Decline in Earnings: What to Look Out for
The market expects Edison International (EIX) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known
Expand Energy (EXE) Earnings Expected to Grow: Should You Buy?
Expand Energy (EXE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
Flowserve (FLS) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Flowserve (FLS) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Earnings Preview: D.R. Horton (DHI) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when D.R. Horton (DHI) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when IQVIA Holdings (IQV) reports results for the quarter ended September 2025. While this widely-known consensus
Armstrong World Industries (AWI) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Armstrong World Industries (AWI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This
Will Caesars Entertainment (CZR) Report Negative Earnings Next Week? What You Should Know
The market expects Caesars Entertainment (CZR) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This
A.O. Smith (AOS) Earnings Expected to Grow: Should You Buy?
A.O. Smith (AOS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
ATI (ATI) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when ATI (ATI) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Visa (V) Earnings Expected to Grow: Should You Buy?
The market expects Visa (V) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is
Earnings Preview: Herc Holdings (HRI) Q3 Earnings Expected to Decline
The market expects Herc Holdings (HRI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Interpublic Group (IPG) to Report Q3 Results: Wall Street Expects Earnings Growth
Interpublic Group (IPG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Group 1 Automotive (GPI) Reports Next Week: Wall Street Expects Earnings Growth
Group 1 Automotive (GPI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Will Higher DataCenter Revenues Benefit Intel's Q3 Earnings?
Intel Corporation INTC is scheduled to report third-quarter 2025 earnings after the closing bell on Oct. 23. In the to-be-reported quarter, the company is likely to have recorded higher revenues
Best Momentum Stocks to Buy for Oct. 21
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 21:
Verastem, Inc. VSTM: This biopharmaceutical company has a Zacks Rank #1 and
Does Monopar Therapeutics (MNPR) Have the Potential to Rally 42.46% as Wall Street Analysts Expect?
Shares of Monopar Therapeutics Inc. (MNPR) have gained 21.2% over the past four weeks to close the last trading session at $77.15, but there could still be a solid upside left in the stock if
Wall Street Analysts Believe LIQUIDIA CORP (LQDA) Could Rally 50.94%: Here's is How to Trade
Shares of Liquidia Technologies, Inc. (LQDA) have gained 6.7% over the past four weeks to close the last trading session at $24.44, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 53.13% Upside in HIVE Digital Technologies (HIVE): Can the Stock Really Move This High?
Shares of HIVE Digital Technologies (HIVE) have gained 46.3% over the past four weeks to close the last trading session at $5.59, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 68.59% Upside in CorMedix (CRMD): Can the Stock Really Move This High?
CorMedix (CRMD) closed the last trading session at $12.16, gaining 7.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Allegiant Travel (ALGT) Now Trades Above Golden Cross: Time to Buy?
After reaching an important support level, Allegiant Travel Company (ALGT) could be a good stock pick from a technical perspective. ALGT recently experienced a "golden cross" event, which saw its
Here's Why Bank7 (BSVN) Could be Great Choice for a Bottom Fisher
Shares of Bank7 (BSVN) have been struggling lately and have lost 7.1% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock
Wall Street Analysts Predict a 34.8% Upside in Alkermes (ALKS): Here's What You Should Know
Alkermes (ALKS) closed the last trading session at $30.98, gaining 12.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in HeartSciences Inc. (HSCS) lately. While the stock has lost 8.3% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in
Does Teva Pharmaceutical Industries (TEVA) Have the Potential to Rally 28.12% as Wall Street Analysts Expect?
Teva Pharmaceutical Industries Ltd. (TEVA) closed the last trading session at $19.42, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price